We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Lipoxen | LSE:LPX | London | Ordinary Share | GB00B08NWV55 | ORD 0.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 7.875 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMLPX
RNS Number : 6705M
Lipoxen PLC
27 May 2010
+---------------------------------+---------------------------------+
| For immediate release | 27 May 2010 |
+---------------------------------+---------------------------------+
Lipoxen plc
("Lipoxen" or the "Company")
Director dealings
The Company was informed on 27 May 2010 that FDS Pharma Associates and its
related parties disposed of 190,266 ordinary shares of 0.5p each ("Ordinary
Shares") at 9.78 pence each on 29 December 2009.
Following these disposals FDS Pharma Associates and its related parties have an
interest in Lipoxen of 41,965,050 Ordinary Shares, representing 24.41 per cent
of the issued Ordinary Share capital in the Company.
Enquires:
+------------------------------------------+--------------------+
| Lipoxen plc | +44 (0)20 7389 |
| | 5015 |
+------------------------------------------+--------------------+
| M. Scott Maguire, Chief Executive | |
| Officer | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Singer Capital Markets (nominated | +44 (0)20 3205 |
| adviser) | 7500 |
+------------------------------------------+--------------------+
| Jeff Keating / Claes Spång | |
+------------------------------------------+--------------------+
| | |
+------------------------------------------+--------------------+
| Buchanan Communications | +44 (0)20 7466 |
| | 5000 |
+------------------------------------------+--------------------+
| Lisa Baderoon / Catherine Breen | |
+------------------------------------------+--------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSGMGZKDNLGGZM
1 Year Lipoxen Chart |
1 Month Lipoxen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
